Headline Roundup November 18, 2020
Perspectives: Moderna and Pfizer Announce Progress on COVID-19 Vaccines
Summary from the AllSides News Team
Featured Coverage of this Story
The Philadelphia Inquirer
With more than 240,000 Americans dead from the COVID virus and far more hospitalized, our country is desperate for a vaccine that prevents serious cases. Billions of dollars in taxpayer money are being spent to put a stop to the virus, yet drug companies are using predominantly mild cases that produce cold-like symptoms, not infections or serious cases, to test the efficacy of their vaccines. Based on the reviews of trial protocols for seven leading vaccine candidates, including those from Moderna and Pfizer, the British Medical Journal (BMJ) wrote last...
The Hill
Moderna’s 94.5 percent vaccine efficacy rate brings renewed hope that a preventative therapy to reduce the spread of COVID-19 may be close at hand. This news is especially welcome as cases continue to spike across the country. But unless the American people trust it (or any of the other vaccines currently under development for that matter), nothing will change.
Only half of the American adults would receive a coronavirus vaccine if it were available today. That number is down precipitously from over 70 percent in May. Even more startling, a...
New York Post (News)
At last, light at the end of the COVID-19 tunnel: At least two highly effective vaccines should begin distribution before year’s end.
Moderna this week followed Pfizer in announcing plans to have a vaccine on the market by the end of December, and other companies are likely to soon follow.
US Health Secretary Alex Azar expects enough doses to vaccinate 20 million Americans before Jan. 1, with a real hope of universal US vaccination by mid-2021.
Thank President Trump’s Operation Warp Speed for not only funding research and the development...
AllSides Picks
Blog
Media Bias Alert: DOJ Claims Biden Admin Weaponized Gov’t to ‘Chill Free Speech’ Despite Internal Dissent
Andy Gorel
October 8th, 2026
Red Blue Translator
Anti-vaxxer
Headline Roundup
Democrats Win House and Senate
November 3rd, 2026
Blog
The Election is over. What comes next?
AllSides Staff
November 4th, 2026
